- Issuer ticker
-
QTTB
- Reported as of
-
12 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
16 Jun 2026, 16:30:26 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Eric Bell, Attorney-in-Fact
Key filing fact
Mary Thistle filed Form 4 for Q32 Bio Inc. (QTTB) on 16 Jun 2026.
Key facts
- This page summarizes Mary Thistle's Form 4 filing for Q32 Bio Inc. (QTTB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2026, 16:30.
Change
- Previous filing in this sequence was filed on 12 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001317917
Primary reporting owner
Thistle Mary
- Relationship
-
Director
- Address
- Q32 BIO INC., 830 WINTER STREET, WALTHAM
- Signature
- /s/ Eric Bell, Attorney-in-Fact
- Signature date
- 16 Jun 2026
This filing has been restated.
Open the amended filing.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QTTB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +9,810
- Change %
- Price
-
$0.000000*
- Shares after
- 9,810
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,810
- Exercise price
- $12.64
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote